Healthcare - Biotechnology - NASDAQ - US
$ 59.46
-1.99 %
$ 1.77 B
Market Cap
-15.05
P/E
CASH FLOW STATEMENT
-73.5 M
OPERATING CASH FLOW
-89 K
INVESTING CASH FLOW
239 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Disc Medicine, Inc.
| Net Income | -76.4 M |
| Depreciation & Amortization | 100 K |
| Capital Expenditures | -89 K |
| Stock-Based Compensation | 5.53 M |
| Change in Working Capital | -2.95 M |
| Others | 1.08 M |
| Free Cash Flow | -73.6 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|
| OPERATING CASH FLOW | ||||
| Net Income | (76.4) | (46.8) | (36.0) | (40.8) |
| Depreciation & Amortization | 100 K | 89 K | 32 K | 0.3 |
| Deferred Income Tax | 0 | 0 | 5.0 | 8 K |
| Stock Based Compensation | 5.5 | 2.09 K | 507 | 123 |
| Other Operating Activities | 0.3 | 0.3 | 1.6 | 6.5 |
| Change in Working Capital | (3.0) | 2.1 | 1.3 | 0.3 |
| Cash From Operations | (73.5) | (42.3) | (27.5) | (32.7) |
| INVESTING CASH FLOW | ||||
| Capital Expenditures | 89 K | (0.2) | 68 K | 22 K |
| Other Items | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 89 K | (0.2) | 68 K | 22 K |
| FINANCING CASH FLOW | ||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 14.0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 40.3 | 95.5 | 89.9 | 20.2 |
| Cash From Financing Activities | 239.4 | 149.0 | 89.9 | 34.2 |
| CHANGE IN CASH | ||||
| Net Change In Cash | 165.8 | 106.6 | 62.3 | 1.5 |
| FREE CASH FLOW | ||||
| Free Cash Flow | (73.6) | (42.4) | (27.6) | (32.7) |